127,976 Shares in Innospec Inc. $IOSP Purchased by Jupiter Topco LLC

Jupiter Topco LLC acquired a new stake in shares of Innospec Inc. (NASDAQ:IOSP) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 127,976 shares of the specialty chemicals company’s stock, valued at approximately $10,417,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Meeder Asset Management Inc. bought a new position in shares of Innospec in the second quarter worth approximately $36,000. Hantz Financial Services Inc. raised its holdings in Innospec by 271.0% in the 4th quarter. Hantz Financial Services Inc. now owns 575 shares of the specialty chemicals company’s stock worth $44,000 after acquiring an additional 420 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Innospec by 1,159.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after acquiring an additional 487 shares in the last quarter. Danske Bank A S bought a new position in Innospec in the 3rd quarter valued at approximately $46,000. Finally, Caitong International Asset Management Co. Ltd boosted its stake in Innospec by 316.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 662 shares of the specialty chemicals company’s stock valued at $51,000 after purchasing an additional 503 shares during the last quarter. 96.64% of the stock is currently owned by institutional investors.

Innospec Trading Up 0.0%

Shares of IOSP opened at $95.38 on Friday. The firm has a fifty day simple moving average of $87.14 and a two-hundred day simple moving average of $80.99. The firm has a market cap of $2.35 billion, a PE ratio of 19.47, a P/E/G ratio of 2.53 and a beta of 0.93. Innospec Inc. has a 1-year low of $65.51 and a 1-year high of $96.68.

Innospec (NASDAQ:IOSP) last released its quarterly earnings results on Tuesday, August 4th. The specialty chemicals company reported $1.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.05 by $0.22. Innospec had a return on equity of 9.22% and a net margin of 6.60%.The firm had revenue of $491.40 million for the quarter, compared to the consensus estimate of $457.25 million. During the same period last year, the business posted $1.26 EPS. The company’s revenue for the quarter was up 11.8% on a year-over-year basis. As a group, research analysts forecast that Innospec Inc. will post 5.03 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

IOSP has been the subject of a number of research analyst reports. Wall Street Zen raised Innospec from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Weiss Ratings raised Innospec from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 6th. Finally, Seaport Research Partners reissued a “buy” rating and issued a $110.00 target price on shares of Innospec in a research report on Thursday, August 6th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Innospec Company Profile

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.